1-Chlorocarbonyl-4-Piperidinopiperidine Hydrochloride CAS 143254-82-4 Irinotecan Hydrochloride Intermediate Purity High
Produsén Pasokan Irinotecan sareng Panganteur Patali:
Irinotecan Hydrochloride CAS: 100286-90-6
Irinotecan Free Base CAS: 97682-44-5
Irinotecan Hydrochloride Trihydrate CAS: 136572-09-3
7-Étil-10-Hydroxycamptothecin CAS: 86639-52-3
1-Chlorocarbonyl-4-Piperidinopiperidine Hydrochloride CAS: 143254-82-4
Ngaran Kimia | 1-Chlorocarbonyl-4-Piperidinopiperidine Hydrochloride |
Nomer CAS | 143254-82-4 |
Nomer CAT | RF-PI243 |
Status saham | Dina Stok, Skala Produksi Nepi ka Ton |
Formula Molekul | C11H20Cl2N2O |
Beurat Molekul | 267.2 |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bubuk Bodas atanapi Lampu Konéng |
Assay | ≥98,0% (HPLC) |
Leungitna dina Drying | ≤1,0% |
Logam beurat | ≤20ppm |
Standar tés | Standar Perusahaan |
Pamakéan | Panganteur Irinotecan Hydrochloride (CAS: 100286-90-6) |
Bungkusan: Botol, kantong Aluminium foil, kardus drum, 25kg / Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap jeung infestation hama.
Shanghai Ruifu Chemical Co., Ltd. nyaéta produsén ngarah sareng supplier 1-Chlorocarbonyl-4-Piperidinopiperidine Hydrochloride (CAS: 143254-82-4) kalayan kualitas luhur.Ieu mangrupa perantara ilaharna dina sintésis Irinotecan Hydrochloride (CAS: 100286-90-6), hiji DNA Topoisomerase I Inhibitor.
lrinotecan hydrochloride, semi-sintétik, turunan larut cai tina camptothecin agén antikanker potent, diluncurkeun di Jepang pikeun pengobatan kanker paru-paru, ovarium, sareng serviks.lrinotecan tiasa ngalaksanakeun kagiatan antitumor na ku cara ngahambat topoisomerase I, énzim sélulér anu aub dina ngajaga struktur topografi DNA salami prosés translasi, transkripsi, sareng mitosis.lrinote tiasa ngalaman de-ésterifikasi in vivo pikeun ngahasilkeun métabolit aktif, SN-38, anu 1000 kali langkung kuat tibatan indungna.Sanajan keur loba kurang toksik ti camptothecin, sajumlah signifikan pasien dina uji klinis exhibited efek samping tina leukopenia, diare, nauseahromiting, sarta alopecia.